Melbourne healthtech company Heidi Health has closed a $65 million Series B funding round led by Point72 Private Investments, with continued support from existing investors Blackbird, Headline and Latitude, bringing the company’s total funding to date to nearly $100 million.
According to a news release, the new funding will support Heidi’s mission to build an AI Care Partner that works alongside clinicians by automating administrative tasks such as documentation and follow-up communications, ultimately freeing up clinicians to focus more on patient care.
In addition, the funding will be used to expand Heidi’s team and increase adoption of its technology in North America and Western Europe.
“It is untenable that healthcare demand continues to rise while clinical time continues to shrink. Building a sustainable healthcare system requires expanding clinical capacity without compromising clinician wellbeing or patient safety. That’s why I founded Heidi: to build an AI Care Partner that stands alongside clinicians, empowering them to deliver the care to which they have dedicated their lives,” Dr. Thomas Kelly, CEO of Heidi, said in a statement.
Over the past 18 months, Heidi reports that it has supported more than 70 million patient consults and is currently enabling over 2 million consults each week across 116 countries and in 110 languages.
